Slc35d3對(duì)脂肪、肝臟、腎臟組織中脂代謝的影響
[Abstract]:Background and objective Obesity is a complex chronic disease and one of the most important manifestations of metabolic syndrome in the 21st century. Obesity is closely associated with risk factors for cardiovascular disease, such as insulin resistance, diabetes, hypertension, and dyslipidemia. The liver is the largest fatty acid synthesis and metabolic organ in the body. The synthesized fatty acids are released into the blood with the help of apolipoprotein and stored in the lipid bank or provide energy for other tissues and organs. Adipose tissue is the largest energy storage organ in the body. The excess energy is stored in the form of fat. When the energy is insufficient, fat mobilization occurs to meet the needs of the body. Fatty degeneration is easy to occur in parenchymal organs such as liver, heart and kidney, in which lipid metabolism is crucial. SLC35D3 gene encodes a nucleotide transporter. It has been reported that Slc35d3 is a candidate gene for obesity or metabolic syndrome, whose protein is located in the endoplasmic reticulum and interacts with D1R. Mice with Slc35d3 gene mutation can attenuate dopamine signal in striatal neurons. This led to metabolic syndrome, and mutations in the SLC35D3 gene were found in two patients with metabolic syndrome. The purpose of this study was to investigate the effect of SLC35D3 gene on lipid metabolism in fat, liver and kidney tissues. Methods the changes of Slc35d3 mRNA transcription in fat, liver and kidney of DIOB6J (diet-induced obesity) mice, ob/ob (leptin deficient) mice and normal control C57BL/6J mice were detected by fluorescence quantitative PCR. Human SLC35D3 gene was electrotransfected into human adipocytes 6 days after differentiation of 3T3-L1. The effects of SLC35D3 gene on differentiation index and mRNA level of lipid metabolism related gene were observed. At the same time, glucose consumption was also detected. At the same time, the SLC35D3 gene was overexpressed in HepG2 cells by liposome transfection. After two days of transfection, the effect of liposome transfection on the mRNA level of lipid metabolism-related genes was detected. On the third day, 1000uM oleic acid and palmitic acid were used to detect the expression of lipid metabolism-related gene mRNA for 24 h, and the normal medium was restored to culture for 24 h after stimulation, and the effect on the mRNA level of lipid metabolism-related gene was detected. Human SLC35D3 gene was transfected into 293T cells by liposome. The changes of lipid metabolism-related gene transcription level were detected after transfection for 2 days. Results in DIO B6J mice and ob/ob obese mice, the transcription level of Slc35d3 in fat and kidney tissues was significantly lower than that in C57BL/6J control group (P0.01). In the liver tissue of obese mice, the transcription level of Slc35d3 was significantly higher than that of control group (P0.01). After 6 days of differentiation of 3T3-L1 preadipocytes, human SLC35D3 gene was overexpressed. The expression of adipocyte differentiation index gene and lipid metabolism-related gene mRNA was significantly decreased, but glucose consumption was not significantly different. HepG2 cells overexpressed human SLC35D3 gene. The mRNA expression of lipid metabolism-related genes was also significantly decreased, and the mRNA expression of lipid metabolism-related genes was also significantly decreased after 293T cells over-expressed the human SLC35D3 gene. Conclusion SLC35D3 can be used as a candidate gene for the study of obesity or metabolic syndrome because of its down-regulation of adipocyte differentiation related genes and lipid metabolism-related genes in adipose, liver and kidney tissues.
【學(xué)位授予單位】:北京協(xié)和醫(yī)學(xué)院
【學(xué)位級(jí)別】:碩士
【學(xué)位授予年份】:2017
【分類號(hào)】:R589.2
【相似文獻(xiàn)】
相關(guān)期刊論文 前10條
1 葉平;;前言——脂代謝與老年心腦血管疾病[J];實(shí)用老年醫(yī)學(xué);2010年04期
2 趙萬(wàn)春;范成文;;脂代謝與免疫球蛋白在慢性阻塞性肺疾病中的表達(dá)研究[J];檢驗(yàn)醫(yī)學(xué)與臨床;2013年20期
3 吳育紅,張愛珍;甘油二酯對(duì)脂代謝的影響及其可能機(jī)制[J];浙江醫(yī)學(xué);2005年04期
4 虞定海;;6個(gè)月健身氣功·五禽戲鍛煉前后中老年人脂代謝變化[J];中國(guó)運(yùn)動(dòng)醫(yī)學(xué)雜志;2008年05期
5 劉延杰;季虹;榮海欽;;鋅α_2糖蛋白對(duì)體質(zhì)量及脂代謝的影響[J];醫(yī)學(xué)綜述;2010年02期
6 林爛芳;胡斌;李淑元;呂明;楊亞軍;袁子宇;王笑峰;;不同勞動(dòng)者類型脂代謝相關(guān)表型的差異分析[J];現(xiàn)代生物醫(yī)學(xué)進(jìn)展;2012年16期
7 侯茗,李磊;影響脂代謝的因素及防治[J];長(zhǎng)春中醫(yī)學(xué)院學(xué)報(bào);2001年03期
8 尹黎明,石元?jiǎng)?燕麥對(duì)脂代謝影響的研究進(jìn)展[J];局解手術(shù)學(xué)雜志;2004年05期
9 余國(guó)膺;;知難而進(jìn),研究糖、脂代謝復(fù)雜網(wǎng)絡(luò)[J];中國(guó)心臟起搏與心電生理雜志;2007年04期
10 康忠漢,劉小鵬;微量元素與脂代謝[J];廣東微量元素科學(xué);1995年09期
相關(guān)會(huì)議論文 前10條
1 孫桂菊;蔡慧珍;劉?;左平國(guó);劉莎;;餐后脂代謝在不同人群脂肪代謝研究中的應(yīng)用[A];達(dá)能營(yíng)養(yǎng)中心第十三屆學(xué)術(shù)研討會(huì)“膳食脂肪與健康”論文集[C];2010年
2 胡金鹿;陳偉平;卓瑪麗;;蠶蛹油對(duì)高脂膳食大鼠血脂及脂代謝相關(guān)酶的影響[A];膳食變遷對(duì)民眾健康的影響:挑戰(zhàn)與應(yīng)對(duì)——第二屆兩岸四地營(yíng)養(yǎng)改善學(xué)術(shù)會(huì)議學(xué)術(shù)報(bào)告及論文摘要匯編[C];2010年
3 常永生;;KLF12在脂代謝中的相關(guān)作用[A];第11屆全國(guó)脂質(zhì)與脂蛋白學(xué)術(shù)會(huì)議論文匯編[C];2012年
4 高淑杰;張明亮;吳翊馨;張肅;;玉米肽對(duì)中年人脂代謝的影響[A];中國(guó)生理學(xué)會(huì)第23屆全國(guó)會(huì)員代表大會(huì)暨生理學(xué)學(xué)術(shù)大會(huì)論文摘要文集[C];2010年
5 汪俊軍;;脂代謝相關(guān)指標(biāo)檢測(cè)技術(shù)與認(rèn)識(shí)新進(jìn)展[A];第一次全國(guó)中西醫(yī)結(jié)合檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議暨中國(guó)中西醫(yī)結(jié)合學(xué)會(huì)檢驗(yàn)醫(yī)學(xué)專業(yè)委員會(huì)成立大會(huì)論文匯編[C];2014年
6 易倫朝;吳海;袁大林;梁逸曾;;基于HRFAB-MS-ULDA的2型糖尿病脂代謝譜判別分析[A];中國(guó)化學(xué)會(huì)第26屆學(xué)術(shù)年會(huì)化學(xué)信息學(xué)與化學(xué)計(jì)量學(xué)分會(huì)場(chǎng)論文集[C];2008年
7 劉婧;溫宇;胡秀芬;張敏;;促;鞍讓(duì)3T3-L1脂肪細(xì)胞脂代謝的影響[A];中華醫(yī)學(xué)會(huì)第十七次全國(guó)兒科學(xué)術(shù)大會(huì)論文匯編(上冊(cè))[C];2012年
8 鄭素潔;;無(wú)癥狀健康體檢者尿酸水平與脂代謝關(guān)系的研究[A];中華醫(yī)學(xué)會(huì)第七次全國(guó)中青年檢驗(yàn)醫(yī)學(xué)學(xué)術(shù)會(huì)議論文匯編[C];2012年
9 吉玲;王與章;崔吉君;;真珠鈣對(duì)高血壓病患者脂代謝的影響[A];鈣劑的基礎(chǔ)研究及臨床應(yīng)用——'96全國(guó)第一屆鈣劑研討會(huì)論文錄[C];1996年
10 徐杰;李國(guó)平;唐蔚青;黎健;;在HepG2細(xì)胞中11β-HSD1通過(guò)SREBP1調(diào)控脂代謝[A];第十二屆全國(guó)脂質(zhì)與脂蛋白學(xué)術(shù)會(huì)議論文匯編[C];2014年
相關(guān)重要報(bào)紙文章 前3條
1 李山;德找到9個(gè)干擾脂代謝的基因變異[N];科技日?qǐng)?bào);2010年
2 記者 白毅;首張秀麗線蟲脂代謝途徑網(wǎng)絡(luò)圖繪成[N];中國(guó)醫(yī)藥報(bào);2013年
3 李明;國(guó)內(nèi)首個(gè)脂代謝腫瘤新藥德氮吡格有望兩年后使用[N];醫(yī)藥經(jīng)濟(jì)報(bào);2007年
相關(guān)博士學(xué)位論文 前1條
1 陳志;奶山羊乳腺組織乳脂代謝關(guān)鍵miRNA的篩選及功能驗(yàn)證[D];西北農(nóng)林科技大學(xué);2017年
相關(guān)碩士學(xué)位論文 前8條
1 苑萌萌;Slc35d3對(duì)脂肪、肝臟、腎臟組織中脂代謝的影響[D];北京協(xié)和醫(yī)學(xué)院;2017年
2 李春燕;日糧煙酸水平對(duì)生長(zhǎng)獺兔生產(chǎn)性能、血清抗氧化及脂肪代謝的影響[D];山東農(nóng)業(yè)大學(xué);2015年
3 龍小娟;牛AGPAT6基因遺傳多態(tài)性研究及與脂代謝相關(guān)功能的驗(yàn)證[D];吉林大學(xué);2016年
4 楚璐雅;瑪咖對(duì)人體抗氧化能力、免疫功能以及脂代謝的影響[D];北京體育大學(xué);2016年
5 吳晶;Kisspeptin-10對(duì)鵪鶉產(chǎn)蛋啟動(dòng)及肝臟脂代謝的影響研究[D];南京農(nóng)業(yè)大學(xué);2012年
6 劉悅;甘油激酶與核受體Nur77相互作用及其對(duì)肝臟脂代謝調(diào)控研究[D];天津大學(xué);2012年
7 李玉婷;IL-17、p-S6在狼瘡性腎炎患者腎臟組織中的表達(dá)[D];昆明醫(yī)科大學(xué);2016年
8 趙艷君;抗增殖蛋白在單側(cè)輸尿管梗阻大鼠腎臟組織中的表達(dá)及全反式維甲酸的干預(yù)[D];廣西醫(yī)科大學(xué);2009年
,本文編號(hào):2378216
本文鏈接:http://sikaile.net/yixuelunwen/nfm/2378216.html